Sixuan LiCEO and President at CICS AnalyticsSpeaker
Profile
Dr. Sixuan Li is the CEO and Co-Founder of CICS Analytics, a techbio company pioneering single-particle analytics for RNA therapeutics. CICS Analytics has developed breakthrough CICS (Cylindrical Illumination Confocal Spectroscopy) technology that provides unprecedented insights to address critical gaps to improve patient outcomes through better therapeutic development and manufacturing.Dr. Li earned his PhD in Biomedical Engineering from Johns Hopkins University, where he developed the foundational CICS technology advised by Dr. Tza-Huei Wang. His work has resulted in multiple patents and peer-reviewed publications advancing single-molecule detection for nanoparticle characterization.